Convergence Investment Partners, LLC Haemonetics Corp Transaction History

Convergence Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $2.01 Million - $2.59 Million	-22,200 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $1.55 Million - $1.98 Million	-17,279 Reduced 43.77%	22,200 $2.54 Million
Q2 2018 Aug 07, 2018	BUY	$71.53 - $95.75 $1.54 Million - $2.07 Million	21,587 Added 120.65%	39,479 $3.54 Million
Q1 2018 May 14, 2018	SELL	$60.72 - $74.41 $1.05 Million - $1.28 Million	-17,248 Reduced 49.08%	17,892 $1.31 Million
Q4 2017 Jan 16, 2018	SELL	$44.96 - $58.99 $8,542 - $11,208	-190 Reduced 0.54%	35,140 $2.04 Million
Q3 2017 Nov 13, 2017	BUY	$40.38 - $44.87 $1.43 Million - $1.59 Million	35,330	35,330 $1.59 Million

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.02B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.